ClinicalTrials.govpublic full text
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
bronchial asthma (only the patients with severe or intractable bronchial asthma which could not be controlled with the existing therapy), observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907784
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.